Latest Conference Articles

The understood link between diabetes and cardiovascular disease (CVD) has played a key role in shaping clinical trials on diabetes medications, according to a presentation at the American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition.

Dr. Baird said that it is important for pharmacy professionals to embrace these changes in technology, and he offered some advice for how to go about embracing the changes.

Pharmacists at Oklahoma State University Medical Center (OSUMC) are fighting infectious diseases with cutting-edge technology.

In this clip, Baxter Pharmacy Consultant Jason Demuth discusses the importance of building a master library for smart pumps.

Although administering intravenous (IV) medication via smart infusion pumps has led to improvements in patient safety, common errors persist with the use of these devices, according to a presentation at the American Society of Health System Pharmacists Midyear Clinical Meeting and Exhibition.

At the ASHP Midyear 2017 meeting, Amy Westmoreland, pharmacy manager and clinical pharmacist at Carilion Giles Community Hospital discusses the importance of collaboration between hospital pharmacists and physicians.

Current pharmacy technician members of ASHP will be automatically incorporated into the forum.

ASHP officials took time to recognize some of their own.

Several people were honored this week at Baxter Healthcare Corporation’s Leadership Excellence Awards in Pharmacy, or LEAP, ceremony.

FDA officials discuss safety data and drug approvals at the American College of Rheumatology Annual Meeting.

A significant portion of patients with rheumatoid arthritis may develop cardiovascular disease.

With the growing use of cancer immunotherapies, rheumatologists expect to see more cases of inflammatory conditions.

Patients with osteoarthritis may be able to receive targeted therapy based on phenotypes.

Major adverse cardiovascular event rates for baricitinib stabilize over time.

Methotrexate discontinuation was not observed to impact rheumatoid arthritis treatment with tocilizumab, according to an abstract presented at the 2017 American College of Rheumatology Annual Meeting.

Some patients with rheumatoid arthritis require a refined treat-to-target plan.

Low incidence of 14-3-3η in patients with long-term RA, chronic HCV with arthralgias.

Treatment for psoriatic arthritis may impact symptoms and patient-reported outcomes.

Flares and immune-related adverse events are common among patients with rheumatologic diseases but can often be successfully managed.

Study finds improved mental health resources and non-pharmacologic treatment options may be effective in reducing reduce opioid exposure among children with juvenile fibromyalgia syndrome.

Patients with active psoriatic arthritis experience significant work instability based on disease activity.

Study finds high unmet need among patients with uncontrolled gout.

Biomarker identification may improve abatacept (Orencia) treatment for rheumatoid arthritis.

Patients with rheumatoid arthritis who switched to biologics or triple therapy had a longer time to treatment failure versus augmented oral methotrexate.

Several modalities found to be effective in the triage of psoriasis patients with musculoskeletal symptoms, according to a study presented at the 2017 American College of Rheumatology meeting.

Current treatment options for dermatomyositis may be ineffective for some patients, according to a study presented at the American College of Rheumatology Annual Meeting.

Medivir to present positive data at the annual meeting of the American College of Rheumatology.

Veterinary products offer pharmacists a chance to diversify their revenue streams.